The art of noise: recent regulatory developments in measuring efficiency
Related
< 1 minute read
Podcasts
AI and fairness: who captures the gains and who is bearing the costs?
Who benefits from AI’s economic value? Much of the discussion around AI focuses on the tasks the technology is replacing. But arguably just as important are the economic questions about competitive advantage: who is capturing the gains, and how widely are they being shared? In this episode of… Read More
From uncertainty to causation: a valuation perspective on life sciences disputes
How do you value a product that may never reach the market? How do you distinguish commercial opportunity from scientific possibility? How do you assess loss in markets shaped by regulation, reimbursement and patient behaviour? These are just some of the valuation questions that arise in life sciences… Read More